birth defects from semaglutide Impact of exposure on fetal and neonatal outcomes in pregnant women: a systematic review Wegovy and Ozempic Birth Defect,

Research shows that patients using tirzepatide can expect to lose between 5% to 15% of their initial body mass over several months

[74] Vitamin C at non-cytotoxic concentrations (1 mM) increased the activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro

The introduction of long-acting formulations and combination therapies is transforming the GLP-1 Drug Market

The activity of complex I and IV was reduced in isolated mitochondria after TBI [72]

In these retrospective studies, Triple-negative status, Lymphovascular invasion, Ki67 30%, and High GSH intake were identified as independent risk factors for poor postoperative prognosis in breast cancer chemotherapy patients